MONTI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.250
EU - Europa 6.755
AS - Asia 4.453
SA - Sud America 469
AF - Africa 130
OC - Oceania 93
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.117
RU - Federazione Russa 2.464
SG - Singapore 1.275
IT - Italia 1.191
CN - Cina 1.031
HK - Hong Kong 747
PL - Polonia 701
IE - Irlanda 610
SE - Svezia 541
VN - Vietnam 479
BR - Brasile 375
KR - Corea 365
DE - Germania 259
FI - Finlandia 254
UA - Ucraina 226
FR - Francia 201
GB - Regno Unito 148
IN - India 129
TR - Turchia 105
JP - Giappone 100
AU - Australia 91
CA - Canada 76
CI - Costa d'Avorio 50
AR - Argentina 41
ID - Indonesia 35
BD - Bangladesh 33
JO - Giordania 33
BE - Belgio 31
NL - Olanda 30
IQ - Iraq 28
MX - Messico 24
CH - Svizzera 20
ZA - Sudafrica 17
EC - Ecuador 15
ES - Italia 15
NG - Nigeria 14
CO - Colombia 13
KE - Kenya 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 10
LT - Lituania 10
UZ - Uzbekistan 10
MA - Marocco 9
SA - Arabia Saudita 9
EG - Egitto 8
PK - Pakistan 8
RO - Romania 8
VE - Venezuela 8
AZ - Azerbaigian 7
JM - Giamaica 6
PE - Perù 6
SC - Seychelles 6
TW - Taiwan 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
AM - Armenia 4
DK - Danimarca 4
HN - Honduras 4
KG - Kirghizistan 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CL - Cile 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
OM - Oman 3
PR - Porto Rico 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AT - Austria 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
GD - Grenada 2
IL - Israele 2
LK - Sri Lanka 2
MD - Moldavia 2
MT - Malta 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
VG - Isole Vergini Britanniche 2
AL - Albania 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
Totale 23.146
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.627
Ashburn 1.030
Fairfield 870
Singapore 853
Warsaw 695
Dublin 609
Hong Kong 608
Chandler 588
San Jose 587
Woodbridge 405
Seoul 362
Seattle 353
Cambridge 345
Wilmington 336
Beijing 308
Jacksonville 296
Houston 292
Milan 254
The Dalles 228
Ann Arbor 207
Buffalo 199
Princeton 157
Ho Chi Minh City 154
Hefei 149
Los Angeles 147
Altamura 136
Lauterbourg 136
Lawrence 131
Rome 110
Boston 103
Hanoi 101
Tokyo 99
Boardman 97
Helsinki 90
Melbourne 87
Mumbai 87
Medford 84
Florence 79
Izmir 76
Dallas 74
Munich 64
New York 51
Abidjan 50
Bremen 48
Shanghai 46
Moscow 45
Norwalk 41
San Diego 40
Council Bluffs 39
Falls Church 33
Brussels 31
Paris 31
São Paulo 30
Redondo Beach 28
Naples 26
Turku 23
Figino 22
London 22
Da Nang 21
Frankfurt am Main 21
Jakarta 21
Turin 20
Clifton 19
Dearborn 19
Bern 18
Bologna 18
Dong Ket 18
Orem 18
Toronto 18
Verona 17
Kent 16
Miano 16
Montreal 16
Andover 15
Atlanta 15
Guangzhou 15
Washington 15
Haiphong 14
Hillsboro 14
Abuja 13
Bari 13
Chicago 13
Palermo 13
Stockholm 13
Baghdad 12
Brooklyn 12
Phoenix 12
West Jordan 12
Brasília 10
Can Tho 10
Modena 10
Tashkent 10
Venice 10
Denver 9
Genoa 9
Hải Dương 9
Manchester 9
Padova 9
Rio de Janeiro 9
Belo Horizonte 8
Totale 15.408
Salva come PNG Salva come JPEG
Nome #
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 321
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 319
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 299
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 269
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 263
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 262
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 257
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment 254
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 249
The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy 241
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 234
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 231
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 230
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 228
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 226
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 221
Longitudinal evaluation of liver stiffness and outcomes in patients with chronic hepatitis C before and after short- and long-term IFN-free antiviral treatment 219
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 216
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 216
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 209
Host genetic determinants in HCV-related mixed cryoglobulinemia 205
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 204
Hepatitis C virus in mixed cryoglobulinemia and B cell lymphoma 200
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 196
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 192
Analysis of HCV persistence in patients with sustained virological response 190
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma 188
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 185
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis 184
Infection of peripheral mononuclear blood cells by hepatitis C virus 183
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 182
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 179
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 178
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 177
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 176
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 176
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 176
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 175
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia 175
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 174
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 173
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 171
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 171
Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis 170
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 170
Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients 169
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 169
Host genetic determinants in HCV-related mixed cryoglobulinemia 169
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 168
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 168
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort 167
A PROSPECTIVE-STUDY ON THE PREVALENCE OF ANTI HCV ANTIBODIES AND HCV-RNA IN SERA OF HEMODIALYSIS-PATIENTS 167
T(14;18) translocation in chronic hepatitis C virus infection 165
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 165
Can type C hepatitis infection be complicated by malignant lymphoma? 163
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 162
Vertical transmission of HCV. 160
Hepatitis C virus (HCV) in cryoglobulinaemic leukocytoclastic vasculitis (LCV): could the presence of HCV in skin lesions be related to T CD8+ lymphocytes, HLA-DR and ICAM-1 expression? 159
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 158
Hepatitis C virus infection and B-cell lymphomas 157
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 157
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 157
Lymphotropic virus infection of peripheral blood mononuclear cells in B-cell non-Hodgkin's lymphoma 156
Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life 154
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 153
Hepatitis C virus infection in patients with non-Hodgkin's lymphoma 152
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 151
HCV-related lymphatic and hepatic malignancies are associated with different microRNA expression patterns in PBMCs 151
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 150
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 149
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 149
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 148
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 148
Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia 146
Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease 145
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia 144
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA 144
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 144
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 143
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 141
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 141
Mixed cryoglobulinemia as a possible preneoplastic disorder 139
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 139
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 138
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 137
Hepatitis C virus lymphotropism and possible pathogenetic implications 136
Epatite da virus C e terapia interferonica 136
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 135
Analysis of HBV/HDV infection in the liver transplant model. 135
Comportamento dell'infezione da HCV in pazienti trapiantati per HCC complicante una cirrosi HCV-correlata 135
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 134
IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME 133
Interferon-alpha in mixed cryoglobulinemia patients: a randomized crossover controlled trial 132
Hepatitis C virus (HCV) infection of fresh and cultured peripheral blood mononuclear cells (PBMNC). 132
Type C hepatitis and chronic lymphocytic leukaemia 131
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 131
L'Impiego dell'INterferone Alfa Ricombinante nel Trattamento della Cirrosi Attiva anti-HCV positiva. 131
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 130
Interstitial lung fibrosis in patients with hepatitis C virus infection 129
Totale 17.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.052 13 109 44 58 46 38 32 70 47 25 204 366
2022/20232.576 247 345 134 187 246 531 356 132 268 16 74 40
2023/2024756 39 118 163 31 46 116 11 150 11 22 24 25
2024/20256.898 223 696 457 1.027 2.342 823 82 376 336 124 225 187
2025/20266.897 817 929 478 439 697 258 848 317 681 441 132 860
2026/2027134 134 0 0 0 0 0 0 0 0 0 0 0
Totale 23.213